Special Issue "Antimicrobial Resistance in Gram-Negative Bacteria, 2nd Edition"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 15 July 2021.
Interests: antimicrobial resistance; antimicrobial action; development of antimicrobial agents or adjuvant; microbial transporter; microbial molecular genetics
Special Issues and Collections in MDPI journals
This is the 2nd edition of the Special Issue “Antimicrobial Resistance in Gram-negative Bacteria”. Gram-negative bacteria possess an intrinsic resistance to many antimicrobials because of the bacterium’s outer-membrane barrier, the presence of multidrug efflux transporters, endogenous antimicrobial inactivation, etc. Moreover, Gram-negative bacteria readily acquire resistance to antimicrobial agents via chromosomal mutations and lateral gene transfers. In order to overcome this problem, it is necessary to tackle the development of antibacterial agents, drug resistance inhibitors, antipathogenic factors, and vaccines. Thus, this Special Issue features interdisciplinary studies that build our understanding of the underlying antimicrobial resistance in Gram-negative bacteria. It also covers studies on the development of antibacterial agents and adjuvants against antimicrobial-resistant Gram-negative bacteria.
Prof. Dr. Yuji Morita
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antimicrobial resistance
- antimicrobial responce
- development of antimicrobial agents or adjuvant
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Carbapenem Therapeutic drug monitoring as a strategy to decrease antimicrobial resistance: an overview
Authors: Sharon Lechtig-Wasserman; Liebisch Hans; Nicolás Díaz-Pinilla; Jhosep Blanco; Yuli-Viviana Fuentes-Barrero; Rosa-Helena Bustos
Affiliation: Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, 140013 Chía, Colombia